Salma Fourati

Dr. Salma Fourati

Service de biochimie endocrinienne et oncologique, Pitié-Salpêtrière Hospital, Paris, Île-de-France, France
+1
orcid
Clinical biologist, PhD

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
DSDelphine Sterlin
Delphine Sterlin
AMAlexis Mathian
Alexis Mathian
MMMakoto Miyara
Makoto Miyara
AMAudrey Mohr
Audrey Mohr
FAFrançois Anna
François Anna
GGGuy Gorochov
Guy Gorochov
Early specific antibody responses against SARS-CoV-2 include IgG, IgM, and IgA, but IgA may neutralize virus and control infection to a larger extent.

11 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
DSDelphine Sterlin
Delphine Sterlin
AMAlexis Mathian
Alexis Mathian
MMMakoto Miyara
Makoto Miyara
AMAudrey Mohr
Audrey Mohr
FAFrançois Anna
François Anna
GGGuy Gorochov
Guy Gorochov
A major dogma in immunology has it that the IgM antibody response precedes secondary memory responses built on the production of IgG, IgA and, occasionaly, IgE. Here, we measured acute humoral responses to SARS-CoV-2, including the frequency of antibody-secreting cells and the presence of specific, neutralizing, antibodies in serum and broncho-alveolar fluid of 145 patients with COVID-19. Surprisingly, early SARS-CoV-2-specific humoral responses were found to be typically dominated by antibodies of the IgA isotype. Peripheral expansion of IgA-plasmablasts with mucosal-homing potential was detected shortly after the onset of symptoms and peaked during the third week of the disease. While the specific antibody response included IgG, IgM and IgA, the latter contributed to a much larger extent to virus neutralization, as compared to IgG. However, specific IgA serum levels notably decrease after one month of evolution. These results represent a challenging observation given the present uncertainty as to which kind of humoral response would optimally protect against re-infection, and whether vaccine regimens should consider boosting a potent, although, at least in blood, fading IgA response. One sentence Summary: While early specific antibody response included IgG, IgM and IgA, the latter contributed to a much larger extent to virus neutralization.

1 September 2020 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
NDNathalie Dorison
Nathalie Dorison
PGPauline Gaignard
Pauline Gaignard
ABAurélien Bayot
Aurélien Bayot
AGAntoinette Gelot
Antoinette Gelot
PBPierre Hadrien Becker
Pierre Hadrien Becker
ASAbdelhamid Slama
Abdelhamid Slama

9 September 2023 in Clinical Nutrition
Verified
Journal Article
Closed access
SFSalma Fourati
Salma Fourati
BDBrune de Dreuille
Brune de Dreuille
JBJoanna Bettolo
Joanna Bettolo
CHCoralie Hutinet
Coralie Hutinet
MGMaude Le Gall
Maude Le Gall
JBJohanne Le Beyec-Le Bihan
Johanne Le Beyec-Le Bihan

3 March 2023 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
SFSalma Fourati
Salma Fourati
ADAnne Dumay
Anne Dumay
MRMaryline Roy
Maryline Roy
AWAlexandra Willemetz
Alexandra Willemetz
LRLara Ribeiro-Parenti
Lara Ribeiro-Parenti
JBJohanne Le Beyec-Le Bihan
Johanne Le Beyec-Le Bihan
Extensive intestinal resection leads to Short Bowel Syndrome (SBS), the main cause of chronic intestinal failure. Colon preservation is crucial for spontaneous adaptation, to improve absorption and reduce parenteral nutrition dependence. Fecal microbiota transplantation (FMT), a promising approach in pathologies with dysbiosis as the one observed in SBS patients, was assessed in SBS rats with jejuno‐colonic anastomosis. The evolution of weight and food intake, the lenght of intestinal villi and crypts and the composition of fecal microbiota of Sham and SBS rats, transplanted or not with high fat diet rat microbiota, were analyzed. All SBS rats lost weight, increased their food intake and exhibited jejunal and colonic hyperplasia. Microbiota composition of SBS rats, transplanted or not, was largely enriched with Lactobacillaceae, and α‐ and β‐diversity were significantly different from Sham. The FMT altered microbiota composition and α‐ and β‐diversity in Sham but not SBS rats. FMT from high fat diet rats was successfully engrafted in Sham, but failed to take hold in SBS rats, probably because of the specific luminal environment in colon of SBS subjects favoring aero‐tolerant over anaerobic bacteria. Finally, the level of food intake in SBS rats was positively correlated with their Lactobacillaceae abundance. Microbiota transfer must be optimized and adapted to this specific SBS environment.

19 April 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
TMTarek Mahdi
Tarek Mahdi
ADAurore Desmons
Aurore Desmons
PKPranvera Krasniqi
Pranvera Krasniqi
JLJean-Marc Lacorte
Jean-Marc Lacorte
NKNathalie Kapel
Nathalie Kapel
TEThibaut Eguether
Thibaut Eguether
Short chain fatty acids (SCFAs) are primarily produced in the caecum and proximal colon via the bacterial fermentation of undigested carbohydrates that have avoided digestion in the small intestine. Increasing evidence supports the critical role that SCFAs play in health and homeostasis. Microbial SCFAs, namely butyric acid, serve as a principal energy source for colonocytes, and their production is essential for gut integrity. A direct link between SCFAs and some human pathological conditions, such as inflammatory bowel disease, irritable bowel syndrome, diarrhea, and cancer, has been proposed. The direct measurement of SCFAs in feces provides a non-invasive approach to demonstrating connections between SCFAs, microbiota, and metabolic diseases to estimate their potential applicability as meaningful biomarkers of intestinal health. This study aimed to adapt a robust analytical method (liquid–liquid extraction, followed by isobutyl chloroformate derivatization and GC–MS analysis), with comparable performances to methods from the literature, and to use this tool to tackle the question of pre-analytical conditions, namely stool processing. We focused on the methodology of managing stool samples before the analysis (fresh stool or dilution in either ethanol/methanol, lyophilized stool, or RNAlater®), as this is a significant issue to consider for standardizing results between clinical laboratories. The objective was to standardize methods for future applications as diagnostic tools. In this paper, we propose a validated GC–MS method for SCFA quantification in stool samples, including pre- and post-analytical comparison studies that could be easily used for clinical laboratory purposes. Our results show that using lyophilization as a stool-processing method would be the best method to achieve this goal.